Past CureTalks
Multiple Myeloma: Minimal Residual Disease Testing as an End Point Treatment
Most multiple myeloma patients, even those in complete response, may show signs of relapse at some point of time. So, testing and quantifying Minimal Residual Disease (MRD) has become essential to obtain better prognostic correlations. Researchers believe that MRD testing…
Modern Imaging Techniques in the Diagnosis and Management of Prostate Cancer
Multiparametric MRI (mpMRI) is being considered as a game-changer in prostate cancer treatment and management. Our prostate cancer panel of Mike Scott, Tony Crispino, Allen Edel and Joel Nowak is talking to Dr. Antonio Carlos Westphalen about the current roles…
Novel Technologies to Check Male Fertility Status with Dr. Jamin Brahmbhatt
Male factor infertility accounts for 50% of total cases of troubled conception. Unfortunatley male infertility is not as promptly reported as female infertility which is tracked by Society for Assisted Reproductive Technology database. One key reason for under-reporting of male…
The MMRF Precision Medicine Model – How Close to Multiple Myeloma Cure Are We?
The MMRF has built a unique model that provides the only end-to-end solution in cancer research. This model is based on three interrelated pillars fueled by data generation and integration; collaboration and discovery; and accelerating clinical trials. Integrating this model…
High Risk Pregnancies – Causes and Care
A high risk pregnancy can be life-threatening to the mother as well as the baby. Women must be trained to tell, when they need medical attention themselves, in addition to the baby care training they receive. We are talking to…